Phase I Study of Bosutinib, a Src/Abl Tyrosine Kinase Inhibitor, Administered to Patients with Advanced Solid Tumors
2011 ◽
Vol 18
(4)
◽
pp. 1092-1100
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 3016-3016
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. 2530-2530
◽
2011 ◽
Vol 29
(15_suppl)
◽
pp. 3098-3098
◽
2008 ◽
Vol 26
(15_suppl)
◽
pp. 2530-2530
◽
2008 ◽
Vol 14
(7)
◽
pp. 2075-2081
◽